Singapore Immunology Network (SIgN)
Understanding how closely related coronaviruses circulate seasonally could impact the timing of vaccination against SARS-CoV-2.
Two linear peptides identified by A*STAR researchers on the SARS-CoV-2 spike protein may improve the specificity of serological assays and show potential as vaccine candidates.
Curiox Biosystems, an A*STAR spin-off company, specializes in automated and quantitative cell analysis. Its CEO, Dr. Namyong Kim, shares the story of the company’s success.
The developmental origins of human macrophages suggest that scientists may need to rethink the way they study these important immune cells.
A*STAR scientists have uncovered a novel surface marker that identifies stem cells and potential cancer stem cells in the distal stomach.
Single-cell genomic technology is providing fresh perspectives on the origins of microglia, ancient immune sentinels found in the brain.
Researchers at A*STAR have uncovered a new role for a subset of immune cells in HIV infection and transmission.
Scientists are one step closer to developing effective treatments against Plasmodium vivax parasites thanks to the ability to culture one of its closest cousins.
Applying a machine learning algorithm to the analysis of immunology datasets, A*STAR scientists can now classify immune cell populations with greater precision.
A*STAR scientists have identified a molecular marker for tracing the origins of immune cells that reside inside tissues and organs.
An imaging technique that distinguishes tumor-associated blood vessels from normal ones could pave the way for better clinical management of tumors.